116 related articles for article (PubMed ID: 36993727)
1. Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease.
Wang Z; Zhu S; Jia Y; Wang Y; Kubota N; Fujiwara N; Gordillo R; Lewis C; Zhu M; Sharma T; Li L; Zeng Q; Lin YH; Hsieh MH; Gopal P; Wang T; Hoare M; Campbell P; Hoshida Y; Zhu H
bioRxiv; 2023 Mar; ():. PubMed ID: 36993727
[TBL] [Abstract][Full Text] [Related]
2. Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease.
Wang Z; Zhu S; Jia Y; Wang Y; Kubota N; Fujiwara N; Gordillo R; Lewis C; Zhu M; Sharma T; Li L; Zeng Q; Lin YH; Hsieh MH; Gopal P; Wang T; Hoare M; Campbell P; Hoshida Y; Zhu H
Cell; 2023 Apr; 186(9):1968-1984.e20. PubMed ID: 37040760
[TBL] [Abstract][Full Text] [Related]
3. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
Elife; 2023 Jan; 12():. PubMed ID: 36648330
[TBL] [Abstract][Full Text] [Related]
4. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
Lake AD; Novak P; Hardwick RN; Flores-Keown B; Zhao F; Klimecki WT; Cherrington NJ
Toxicol Sci; 2014 Jan; 137(1):26-35. PubMed ID: 24097666
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets.
Bianco C; Casirati E; Malvestiti F; Valenti L
JHEP Rep; 2021 Jun; 3(3):100284. PubMed ID: 34027340
[TBL] [Abstract][Full Text] [Related]
6. [Identification of
Wang W; Chen D; Piao H
Se Pu; 2021 Oct; 39(10):1118-1127. PubMed ID: 34505434
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Farrell GC; Haczeyni F; Chitturi S
Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
[TBL] [Abstract][Full Text] [Related]
8. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease.
Gaemers IC; Stallen JM; Kunne C; Wallner C; van Werven J; Nederveen A; Lamers WH
Biochim Biophys Acta; 2011 Apr; 1812(4):447-58. PubMed ID: 21216282
[TBL] [Abstract][Full Text] [Related]
9. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
10. MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM.
Tian C; Min X; Zhao Y; Wang Y; Wu X; Liu S; Dou W; Zhou T; Liu Y; Luo R; Li Z; Lui KO; Li Y; Zhou B; Ding Q
J Hepatol; 2022 Dec; 77(6):1491-1503. PubMed ID: 35985547
[TBL] [Abstract][Full Text] [Related]
11. Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression.
Azzu V; Vacca M; Kamzolas I; Hall Z; Leslie J; Carobbio S; Virtue S; Davies SE; Lukasik A; Dale M; Bohlooly-Y M; Acharjee A; Lindén D; Bidault G; Petsalaki E; Griffin JL; Oakley F; Allison MED; Vidal-Puig A
Mol Metab; 2021 Jun; 48():101210. PubMed ID: 33722690
[TBL] [Abstract][Full Text] [Related]
12. Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease.
Zhu M; Lu T; Jia Y; Luo X; Gopal P; Li L; Odewole M; Renteria V; Singal AG; Jang Y; Ge K; Wang SC; Sorouri M; Parekh JR; MacConmara MP; Yopp AC; Wang T; Zhu H
Cell; 2019 Apr; 177(3):608-621.e12. PubMed ID: 30955891
[TBL] [Abstract][Full Text] [Related]
13. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
14. Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis.
Li X; Zhong S; Sun Y; Huang X; Li Y; Wang L; Wu Y; Yang M; Yuan HX; Liu J; Zang S
Front Endocrinol (Lausanne); 2022; 13():951093. PubMed ID: 36329886
[TBL] [Abstract][Full Text] [Related]
15. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
16. The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.
Rolla S; Alchera E; Imarisio C; Bardina V; Valente G; Cappello P; Mombello C; Follenzi A; Novelli F; Carini R
Clin Sci (Lond); 2016 Feb; 130(3):193-203. PubMed ID: 26558403
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Zhao Y; Li Z; Wang C
Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
[TBL] [Abstract][Full Text] [Related]
18. Multiple anti-non-alcoholic steatohepatitis (NASH) efficacies of isopropylidenyl anemosapogenin via farnesoid X receptor activation and TFEB-mediated autophagy.
Zhang N; Wu Y; Zhong W; Xia G; Xia H; Wang L; Wei X; Li Y; Shang H; He H; Lin S
Phytomedicine; 2022 Jul; 102():154148. PubMed ID: 35576742
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.
Lan T; Hu Y; Hu F; Li H; Chen Y; Zhang J; Yu Y; Jiang S; Weng Q; Tian S; Ma T; Yang G; Luo D; Wang L; Li K; Piao S; Rong X; Guo J
J Hepatol; 2022 Feb; 76(2):407-419. PubMed ID: 34656650
[TBL] [Abstract][Full Text] [Related]
20. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
Dasgupta D; Nakao Y; Mauer AS; Thompson JM; Sehrawat TS; Liao CY; Krishnan A; Lucien F; Guo Q; Liu M; Xue F; Fukushima M; Katsumi T; Bansal A; Pandey MK; Maiers JL; DeGrado T; Ibrahim SH; Revzin A; Pavelko KD; Barry MA; Kaufman RJ; Malhi H
Gastroenterology; 2020 Oct; 159(4):1487-1503.e17. PubMed ID: 32574624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
